curasan AG expands distribution network in Europe

Kleinostheim, Germany, 12. April 2021 

curasan AG expands distribution network in Europe

curasan AG, a leading global supplier of medical solutions for regenerative bone healing, osteoarthritis therapy and haemostasis in the dental and orthopaedic fields, has added two strong partners to its European distribution network.

Firstly, Silesia Dental Sp. z o.o. Sp. k. will also distribute the dental products of curasan AG in the Polish market from now on. The company is an established distributor of dental products from well-known manufacturers in Poland.

Furthermore, Implants Diffusion International SARL (IDI), a French manufacturer and distributor of dental implants, will act as an additional dental distributor for curasan AG in France starting in April. IDI is represented in over 30 countries and, with over 85,000 dental implants sold per year and is one of the leading market players in dental implantology in France.

“With IDI Dental, we were able to gain an important strategic partner for our dental business in France. There is still great potential for our products in this country,” says Dirk Dembski, CEO of curasan AG since January 2021. “We also expect a visible increase in our market share from the cooperation with Silesia Dental. Therefore, we are extremely pleased to be able to work with these two distribution partners in the future.”

Press contact at curasan AG:
Andrea Weidner
Head of Corporate Communications
+49 6027 40 900-51
pr@curasan.com

  

About curasan AG:
curasan develops, manufactures and markets biomaterials and medical devices in the field of bone and tissue regeneration, wound healing and osteoarthritis therapy. As a pioneer and global technology leader in the growing field of regenerative medicine, curasan is specialized primarily on biomimetic bone grafting materials for dental, oral/maxillofacial, orthopedic and spinal applications, i.e. materials mimicking biological structures. Numerous patents and a broad record of scientific publications demonstrate the clinical success of the products and the highly innovative strength of curasan. Dental and orthopaedic clinicians worldwide benefit from the broad range of the premium quality and easy to use portfolio offered by the technology leader curasan. curasan maintains its own high-tech facilities for research, development and manufacturing of biomaterials in Frankfurt/Main, Germany. In addition to its headquarters, the company has a subsidiary, curasan, Inc., in Wake Forest, near Raleigh, N.C., USA. curasan´s innovative products are cleared by the US Food and Drug Administration (FDA) and many other international authorities and available in almost 50 countries worldwide.